Literature DB >> 28442387

Establishment of MicroRNA delivery system by PP7 bacteriophage-like particles carrying cell-penetrating peptide.

Yanli Sun1, Yanhua Sun2, Ronglan Zhao3.   

Abstract

MicroRNAs have great therapeutic potential in cancer and other diseases. However, their instability and low in vivo delivery efficiency limits their application. Recombinant PP7 bacteriophage-based virus-like particles (VLPs) could protect microRNAs against rapid degradation by RNase by packaging specific exogenous pre-microRNAs using the pac site. Insertion of a cell-penetrating peptide (CPP) into the AB-loop of VLPs could significantly improve the delivery efficiency of microRNAs into mammalian cells. Unlike other microRNA delivery methods (viral or non-viral vectors), recombinant PP7 VLPs carrying a CPP and microRNA could be efficiently expressed in Escherichia coli using the one-plasmid double expression system. Here we showed that PP7 VLPs carrying a CPP penetrated hepatoma SK-HEP-1 cells and delivered the pre-microRNA-23b, which was processed into a mature product within 24 h; a concentration of 10 nM was sufficient for the inhibition of hepatoma cell migration via the downregulation of liver-intestine cadherin expression. Furthermore, PP7 VLPs carrying a CPP and a pre-microRNA were not infectious, replicative, or cytotoxic. Therefore, recombinant PP7 VLPs can be used for simultaneous and targeted delivery of both microRNAs and peptides because of their ability to package specific exogenous RNA using the pac site and to display peptides.
Copyright © 2017 The Society for Biotechnology, Japan. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CDH17; Cell-penetrating peptides; Hepatoma cells; Liver-intestine cadherin; MicroRNA; Migration; PP7 bacteriophage

Mesh:

Substances:

Year:  2017        PMID: 28442387     DOI: 10.1016/j.jbiosc.2017.03.012

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  8 in total

1.  Engineering the PP7 Virus Capsid as a Peptide Display Platform.

Authors:  Liangjun Zhao; Mykhailo Kopylov; Clinton S Potter; Bridget Carragher; M G Finn
Journal:  ACS Nano       Date:  2019-03-26       Impact factor: 15.881

Review 2.  Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications.

Authors:  Young Hun Chung; Hui Cai; Nicole F Steinmetz
Journal:  Adv Drug Deliv Rev       Date:  2020-06-27       Impact factor: 15.470

Review 3.  The Utilization of Cell-Penetrating Peptides in the Intracellular Delivery of Viral Nanoparticles.

Authors:  Jana Váňová; Alžběta Hejtmánková; Marie Hubálek Kalbáčová; Hana Španielová
Journal:  Materials (Basel)       Date:  2019-08-22       Impact factor: 3.623

4.  Recent Advances in miRNA Delivery Systems.

Authors:  Ishani Dasgupta; Anushila Chatterjee
Journal:  Methods Protoc       Date:  2021-01-20

Review 5.  Modulating microRNAs in cancer: Next-generation therapies.

Authors:  Nahid Arghiani; Khalid Shah
Journal:  Cancer Biol Med       Date:  2021-12-01       Impact factor: 4.248

6.  Global trends in research on miRNA-microbiome interaction from 2011 to 2021: A bibliometric analysis.

Authors:  Xiang-Yun Yan; Jun-Peng Yao; Yan-Qiu Li; Wei Zhang; Meng-Han Xi; Min Chen; Ying Li
Journal:  Front Pharmacol       Date:  2022-08-30       Impact factor: 5.988

Review 7.  Virus-like Particles as Nanocarriers for Intracellular Delivery of Biomolecules and Compounds.

Authors:  Junyao He; Linying Yu; Xiaodi Lin; Xiaoyan Liu; Yanming Zhang; Fan Yang; Wen Deng
Journal:  Viruses       Date:  2022-08-28       Impact factor: 5.818

Review 8.  Noncoding RNA therapeutics - challenges and potential solutions.

Authors:  Melanie Winkle; Sherien M El-Daly; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2021-06-18       Impact factor: 84.694

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.